Back to top
more

Charles River Laboratories International (CRL)

(Delayed Data from NYSE)

$229.03 USD

229.03
322,125

+1.22 (0.54%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $228.97 -0.06 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for CRL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Charles River Laboratories International, Inc. [CRL]

Reports for Purchase

Showing records 341 - 360 ( 377 total )

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 341

11/14/2016

Daily Note

Pages: 28

Healthcare: Post 3Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 342

11/03/2016

Company Report

Pages: 2

Cautious Clients - Buy

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 343

09/30/2016

Company Report

Pages: 2

Powering the Portfolio - Buy

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 344

09/20/2016

Company Report

Pages: 2

Demand Remains - Buy

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 345

08/16/2016

Daily Note

Pages: 11

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 346

08/15/2016

Daily Note

Pages: 28

Healthcare: Post-2Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 347

08/12/2016

Company Report

Pages: 2

More Than Mice - Buy

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 348

08/11/2016

Company Report

Pages: 5

Investor Day Highlights

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 349

08/04/2016

Company Report

Pages: 2

Demand Meets Capacity - Buy

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 350

08/03/2016

Company Report

Pages: 5

Another Beat and Raise

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 351

06/29/2016

Company Report

Pages: 2

Charles River Labs is our top pick for H2 2016.

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 352

05/20/2016

Daily Note

Pages: 14

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 353

05/19/2016

Daily Note

Pages: 29

Healthcare: Post-1Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 354

05/05/2016

Company Report

Pages: 2

CRL reported first quarter 2016 results that exceeded our expectations

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 355

05/04/2016

Company Report

Pages: 5

Starting off on Good Footing for 2016

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 356

05/04/2016

Daily Note

Pages: 3

1Q16 Results

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 357

05/04/2016

Daily Note

Pages: 19

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 358

04/26/2016

Company Report

Pages: 10

Behind the Scenes Success

Provider: G.RESEARCH, LLC

Analyst: WOJDA S

Price: 25.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 359

03/15/2016

Industry Report

Pages: 4

The Bull Market Rages On (Society of Toxicology Recap)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: Charles River Laboratories International, Inc.

Industry: Medical Services

Record: 360

02/11/2016

Company Report

Pages: 5

Focus-Integrations and Debt Reduction

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party